Saba Nayar

Saba Nayar is a Research Fellow in Inflammation and Ageing with significant contributions to immunology and autoimmune disease research. She has an extensive publication record with 53 research outputs and has led or contributed to 6 research projects, including one currently active project on RANKL as a therapeutic target in Sjögren's Syndrome.

Her research focuses on:

• Tertiary Lymphoid Structures and their role in autoimmune conditions
• Autoimmunity mechanisms, particularly in Sjögren's Syndrome
• Inflammatory pathways involving fibroblasts and immune cells
• Salivary gland pathology in autoimmune disorders
• Novel therapeutic targets for inflammatory arthritis

Dr. Nayar's work demonstrates a strong focus on translating basic immunological discoveries into potential clinical applications, with publications in high-impact journals including Nature, Nature Metabolism, and Nature Communications. Her research shows particular expertise in the spatial and molecular analysis of immune structures in autoimmune diseases, with a fingerprint showing 100% focus on Tertiary Lymphoid Structures, 57% on Autoimmunity, and 46% on both Inflammatory Arthritis and Salivary Gland research.

Her scientific recognition includes:

• WT ISSF 2021 (R9): High Impact Publications Award from The Wellcome Trust

Dr. Nayar has established strong collaborative networks, frequently working with researchers like Fisher, B.A. and Barone, F., and has secured funding from organizations including The Wellcome Trust, British Sjögren's Syndrome Association, and pharmaceutical companies such as Servier and Galapagos NV. Her work bridges basic science and clinical applications in autoimmune disease research, with multiple publications gaining significant attention in news outlets and social media platforms.